2 Result(s)
within
Zhen-duo Shi
Biomedicine
Oncology
-
Article
Open AccessTargeting HNRNPU to overcome cisplatin resistance in bladder cancer
The overall response of cisplatin-based chemotherapy in bladder urothelial carcinoma (BUC) remains unsatisfactory due to the complex pathological subtypes, genomic difference, and drug resistance. The genes th...
-
Article
Open AccessIdentification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma
Clear cell renal cell carcinoma (ccRCC) is one of the most lethal urological malignancies, but the pathogenesis and prognosis of ccRCC remain obscure, which need to be better understand.
